| Formulations | Branded generic medicines across therapeutic areas like pain management, cardiovasculars, anti-malarials. | Strong brand portfolio, wide field force, regulatory approvals, established distribution networks globally. | B2C via retail pharmacies, B2B through distributors and healthcare institutions. | Branded formulations in specialized therapeutic areas including pain management and cardiology. | 5374 | 60 | Product sales through marketing divisions in India and international markets. | Direct sales with branded and generic products; varied pricing based on market and therapy. | Increased domestic market penetration, new therapeutic launches, geographic expansion. | Perinorm, Isordil, Activa |
| Active Pharmaceutical Ingredients (APIs) and Intermediates | Bulk drugs and intermediates for manufacture of various formulations sold globally. | Integrated manufacturing, global approvals (USFDA, EDQM), process expertise, diversified API base. | B2B, including global formulators and generic drug manufacturers. | Specialty APIs with patents and regulatory certifications. | 1266 | 14 | Sales to multinational pharma companies and generic manufacturers worldwide. | Contract manufacturing and competitive pricing based on volumes and long-term contracts. | Global demand for high-quality generic APIs and R&D-driven process innovations. | Atenolol, Chloroquine Phosphate, Furosemide, Pyrantel Salts |
